risperidone has been researched along with Chronic Kidney Diseases in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Risperidone, a currently used atypical antipsychotic agent for schizophrenia, is also known to inhibit the activity of D-amino acid oxidase, which degrades certain D-amino acids." | 8.31 | Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study. ( Hara, A; Horikoshi, K; Iwata, Y; Kikuchi, M; Kinoshita, M; Kitajima, S; Minami, T; Mita, M; Miyagawa, T; Nakada, M; Nakade, Y; Nakagawa, S; Ogura, H; Oshima, M; Sakai, N; Shimizu, M; Toyama, T; Wada, T; Yomogida, D; Yuasa, T, 2023) |
| " Risperidone, a currently used atypical antipsychotic agent for schizophrenia, is also known to inhibit the activity of D-amino acid oxidase, which degrades certain D-amino acids." | 4.31 | Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study. ( Hara, A; Horikoshi, K; Iwata, Y; Kikuchi, M; Kinoshita, M; Kitajima, S; Minami, T; Mita, M; Miyagawa, T; Nakada, M; Nakade, Y; Nakagawa, S; Ogura, H; Oshima, M; Sakai, N; Shimizu, M; Toyama, T; Wada, T; Yomogida, D; Yuasa, T, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oshima, M | 1 |
| Toyama, T | 1 |
| Nakade, Y | 1 |
| Yomogida, D | 1 |
| Yuasa, T | 1 |
| Horikoshi, K | 1 |
| Minami, T | 1 |
| Ogura, H | 1 |
| Nakagawa, S | 1 |
| Miyagawa, T | 1 |
| Kitajima, S | 1 |
| Hara, A | 1 |
| Sakai, N | 1 |
| Shimizu, M | 1 |
| Mita, M | 1 |
| Kinoshita, M | 1 |
| Nakada, M | 1 |
| Kikuchi, M | 1 |
| Iwata, Y | 1 |
| Wada, T | 1 |
| Blanco-Dominguez, I | 1 |
| Monsalve, B | 1 |
| Martínez, LM | 1 |
| Oteiza, AV | 1 |
| Bové, M | 1 |
2 other studies available for risperidone and Chronic Kidney Diseases
| Article | Year |
|---|---|
Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study.
Topics: Animals; Antipsychotic Agents; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Mice; Middl | 2023 |
Bilateral anterior ischemic optic neuropathy associated with gastrointestinal hemorrhage and maintenance hemodialysis.
Topics: Aged; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Hypotension; Hypovolem | 2020 |